Bullish option flow detected in Iovance Biotherapeutics with 5,650 calls trading, 1.2x expected, and implied vol increasing almost 4 points to 201.74%. Feb-24 8 puts and Mar-24 11 calls are the most active options, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 0.24. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IOVA:
- Unusually active option classes on open January 26th
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance clinical hold does not impact other trials, says JMP Securities
- Iovance expects to quickly address clinical hold, says Barclays